Publications by authors named "Kati Kivinummi"

17Publications

AR and ERG drive the expression of prostate cancer specific long noncoding RNAs.

Oncogene 2020 Jul 17;39(30):5241-5251. Epub 2020 Jun 17.

Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41388-020-1365-6DOI Listing
July 2020

The expression of AURKA is androgen regulated in castration-resistant prostate cancer.

Sci Rep 2017 12 21;7(1):17978. Epub 2017 Dec 21.

BioMediTech Institute, Faculty of Medicine and Life Sciences, University of Tampere, Fimlab Laboratories, Tampere University Hospital, Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-017-18210-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740165PMC
December 2017

Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer.

Cell Rep 2017 06;19(10):2045-2059

Centre for Molecular Medicine Norway, Nordic European Molecular Biology Laboratory Partnership, Forskningsparken, University of Oslo, 21 0349 Oslo, Norway; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, 0424 Oslo, Norway; PCUK Movember Centre of Excellence, CCRCB, Queen's University, Belfast BT7 1NN, Northern Ireland, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2017.05.049DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675034PMC
June 2017

Measuring the Expression of microRNAs Regulated by Androgens.

Methods Mol Biol 2016 ;1443:151-63

Prostate Cancer Research Center, Institute of Biosciences and Medical Technology-BioMediTech and Fimlab Laboratories, University of Tampere and Tampere University Hospital, Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-3724-0_10DOI Listing
November 2017

Integrated clinical, whole-genome, and transcriptome analysis of multisampled lethal metastatic prostate cancer.

Cold Spring Harb Mol Case Stud 2016 May;2(3):a000752

Prostate Cancer Research Center, Institute of Biosciences and Medical Technology, BioMediTech, University of Tampere and Fimlab Laboratories, Tampere University Hospital, FI-33014 Tampere, Finland;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/mcs.a000752DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853517PMC
May 2016

Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer.

Cancer Res 2015 Oct 17;75(19):4026-31. Epub 2015 Aug 17.

Department of Signal Processing, Tampere University of Technology, Tampere, Finland. Institute of Biosciences and Medical Technology-BioMediTech, University of Tampere, Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-0217DOI Listing
October 2015

CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations.

Oncotarget 2015 Aug;6(23):19661-70

Prostate Cancer Research Center (PCRC), Institute of Biosciences and Medical Technology (BioMediTech), University of Tampere and Tampere University Hospital, Tampere, Finland.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637312PMC
http://dx.doi.org/10.18632/oncotarget.3875DOI Listing
August 2015

DOT1L-HES6 fusion drives androgen independent growth in prostate cancer.

EMBO Mol Med 2014 Sep;6(9):1121-3

Institute of Biosciences and Medical Technology, Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.15252/emmm.201404210DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197859PMC
September 2014